loadpatents
Patent applications and USPTO patent grants for Aguirre; Gustavo D..The latest application filed is for "aav vectors for treatment of dominant retinitis pigmentosa".
Patent | Date |
---|---|
Aav Vectors For Treatment Of Dominant Retinitis Pigmentosa App 20210324387 - Lewin; Alfred S. ;   et al. | 2021-10-21 |
AAV vectors for treatment of dominant retinitis pigmentosa Grant 11,118,185 - Lewin , et al. September 14, 2 | 2021-09-14 |
Compositions And Methods For Treatment Of Dominant Retinitis Pigmentosa App 20210207147 - Lewin; Alfred S. ;   et al. | 2021-07-08 |
AAV-mediated gene therapy for RPGR X-linked retinal degeneration Grant 10,383,922 - Beltran , et al. A | 2019-08-20 |
Aav Vectors For Treatment Of Dominant Retinitis Pigmentosa App 20190093111 - Lewin; Alfred S. ;   et al. | 2019-03-28 |
Aav-mediated Gene Therapy For Rpgr X-linked Retinal Degeneration App 20180036385 - BELTRAN; William A. ;   et al. | 2018-02-08 |
AAV-mediated gene therapy for RPGR X-linked retinal degeneration Grant 9,770,491 - Beltran , et al. September 26, 2 | 2017-09-26 |
Method of Treating or Retarding the Development of Blindness App 20170014529 - Acland; Gregory M. ;   et al. | 2017-01-19 |
Method of Treating or Retarding the Development of Blindness App 20160263246 - Acland; Gregory M. ;   et al. | 2016-09-15 |
Method of treating or retarding the development of blindness Grant 9,433,688 - Acland , et al. September 6, 2 | 2016-09-06 |
Aav-mediated Gene Therapy For Rpgr X-linked Retinal Degeneration App 20150202269 - Beltran; William A ;   et al. | 2015-07-23 |
Method of Treating or Retarding the Development of Blindness App 20140377224 - Acland; Gregory M. ;   et al. | 2014-12-25 |
Method Of Treating Or Retarding The Development Of Blindness App 20130216500 - Acland; Gregory M. ;   et al. | 2013-08-22 |
Method Of Treating Or Retarding The Development Of Blindness App 20120225930 - Acland; Gregory M. ;   et al. | 2012-09-06 |
Method of treating or retarding the development of blindness Grant 8,147,823 - Acland , et al. April 3, 2 | 2012-04-03 |
Method Of Treating Or Retarding The Development Of Blindness App 20100272688 - Acland; Gregory M. ;   et al. | 2010-10-28 |
Method for identifying progressive rod-cone degeneration in dogs Grant 7,811,761 - Acland , et al. October 12, 2 | 2010-10-12 |
Diagnostic test for Collie Eye Anomaly Grant 7,723,507 - Acland , et al. May 25, 2 | 2010-05-25 |
Diagnostic Test For Collie Eye Anomaly App 20090176225 - Acland; Gregory M. ;   et al. | 2009-07-09 |
Method of Treating or Retarding the Development of Blindness App 20090074723 - Acland; Gregory M. ;   et al. | 2009-03-19 |
Diagnostic test for collie eye anomaly Grant 7,462,455 - Acland , et al. December 9, 2 | 2008-12-09 |
Method for identifying progressive rod-cone degeneration in dogs App 20070161033 - Acland; Gregory M. ;   et al. | 2007-07-12 |
Method of treating or retarding the development of blindness App 20070077228 - Acland; Gregory M. ;   et al. | 2007-04-05 |
Diagnostic test for Collie Eye Anomaly App 20060115843 - Acland; Gregory M. ;   et al. | 2006-06-01 |
Identification of congenital stationary night blindness in dogs Grant 6,428,958 - Aguirre , et al. August 6, 2 | 2002-08-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.